摘要 |
Novel 1,3-dihydro-benzimidazol-2-ylidene amine derivatives of formula the addition salts and stereochemically isomeric forms wherein each Alk is C<SUB>1-6</SUB>alkanediyl; Q is hydrogen; C<SUB>1-6</SUB>alkyl substituted with one or two Ar<SUP>2 </SUP>radicals; CI<SUB>1-6</SUB>alkyl substituted with quinolinyl, oxazolidinyl, thiazolidinyl, morpholinyl, thiomorpholinyl, or with pyrrolidinonyl; -CO-Ar<SUP>2</SUP>; or Q is a radical of formula wherein t is 1, 2 or 3; R<SUP>4 </SUP>is amino, mono- or di(C<SUB>1-6</SUB>alkyl)amino; R<SUP>1 </SUP>is Ar<SUP>2</SUP>, -CO-Ar<SUP>2 </SUP>or a monocyclic or bicyclic heterocycle which may optionally be substituted; R<SUP>2 </SUP>is as R<SUP>1 </SUP>and additionally can be hydrogen; where Q is other than hydrogen, R<SUP>3 </SUP>is hydrogen; and where Q is other than hydrogen, R<SUP>3 </SUP>is a radical: wherein R<SUP>6 </SUP>is hydrogen, C<SUB>1-6</SUB>alkyl, substituted C<SUB>1-6</SUB>alkyl; R<SUP>7</SUP>, R<SUP>8</SUP>, R<SUP>9 </SUP>are halo, cyano, C<SUB>1-6</SUB>alkyl, substituted C<SUB>1-6</SUB>alkyl, C<SUB>2-6</SUB>alkenyl, cyanoC<SUB>2-6</SUB>alkenyl, C<SUB>2-6</SUB>alkynyl, cyanoC<SUB>2 6</SUB>alkynyl, Ar<SUP>1</SUP>, R<SUP>10a</SUP>-0-, R<SUP>10a </SUP>-S-, -N(R<SUP>5a</SUP>R<SUP>5b</SUP>), R<SUP>10a</SUP>-O-C(-O)-, N(R<SUP>5a</SUP>R<SUP>5b</SUP>)-C(-O)-, R<SUP>10a</SUP>-C(-O)-NR<SUP>5b</SUP>1', R<SUP>10b</SUP>-C(-O)-O-; and R<SUP>8 </SUP>and/or R<SUP>9 </SUP>may also be hydrogen; which are RSV inhibitors. Compositions containing these compounds and processes for preparing these compounds and compositions.
|